SOTIO Presents Positive Biomarker Data from DCVAC/OvCa Phase 2 Study in First Line Ovarian Cancer at the 2021 ASCO Annual Meeting
PRAGUE, Czech Republic, June 04, 2021 (GLOBE NEWSWIRE) -- SOTIO, a clinical stage immune-oncology company owned by PPF Group, today...